Shares of NanoViricides Inc. (NNVC) have been trading in the range of $1.27 – $19.20 for the past one year, and closed Tuesday’s trade at $6.92, down 8 cents or 1.14%. Currently, the stock is trading at $10.43, up $3.51 or 50.72% in the pre-market session.
The company announced that excellent safety and tolerability of the drug candidates it is developing against SARS-CoV-2 to treat COVID-19 spectrum of diseases was observed in an animal model.
The nanoviricides drug candidates tested in this safety/tolerability study have previously demonstrated strong effectiveness against lung infection by a SARS-CoV-2 like coronavirus, namely, hCoV-NL63, in an animal study as previously reported by the company.
Source: Read Full Article